cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity ST Ferris, V Durai, R Wu, DJ Theisen, JP Ward, MD Bern, JT Davidson IV, ... Nature 584 (7822), 624-629, 2020 | 368 | 2020 |
Migratory CD11b+ conventional dendritic cells induce T follicular helper cell–dependent antibody responses JK Krishnaswamy, U Gowthaman, B Zhang, J Mattsson, L Szeponik, D Liu, ... Science immunology 2 (18), eaam9169, 2017 | 207 | 2017 |
Long-term culture captures injury-repair cycles of colonic stem cells Y Wang, IL Chiang, TE Ohara, S Fujii, J Cheng, BD Muegge, A Ver Heul, ... Cell 179 (5), 1144-1159. e15, 2019 | 150 | 2019 |
Cryptic activation of an Irf8 enhancer governs cDC1 fate specification V Durai, P Bagadia, JM Granja, AT Satpathy, DH Kulkarni, JT Davidson IV, ... Nature immunology 20 (9), 1161-1173, 2019 | 117 | 2019 |
Activation-induced cytidine deaminase expression in human B cell precursors is essential for central B cell tolerance T Cantaert, JN Schickel, JM Bannock, YS Ng, C Massad, T Oe, R Wu, ... Immunity 43 (5), 884-895, 2015 | 81 | 2015 |
Coincidental loss of DOCK8 function in NLRP10-deficient and C3H/HeJ mice results in defective dendritic cell migration JK Krishnaswamy, A Singh, U Gowthaman, R Wu, P Gorrepati, ... Proceedings of the National Academy of Sciences 112 (10), 3056-3061, 2015 | 72 | 2015 |
Ablation of cDC2 development by triple mutations within the Zeb2 enhancer TT Liu, S Kim, P Desai, DH Kim, X Huang, ST Ferris, R Wu, F Ou, T Egawa, ... Nature 607 (7917), 142-148, 2022 | 40 | 2022 |
BCL6-dependent TCF-1+ progenitor cells maintain effector and helper CD4+ T cell responses to persistent antigen Y Xia, K Sandor, JA Pai, B Daniel, S Raju, R Wu, S Hsiung, Y Qi, ... Immunity 55 (7), 1200-1215. e6, 2022 | 33 | 2022 |
cDC1 vaccines drive tumor rejection by direct presentation independently of host cDC1 ST Ferris, RA Ohara, F Ou, R Wu, X Huang, S Kim, J Chen, TT Liu, ... Cancer immunology research 10 (8), 920-931, 2022 | 31 | 2022 |
Mechanisms of CD40-dependent cDC1 licensing beyond co-stimulation R Wu, O RA, S Jo, T Murphy, K Murphy The Journal of Immunology 208 (1_Supplement), 61.18, 2022 | 27 | 2022 |
DCs at the center of help: Origins and evolution of the three-cell-type hypothesis R Wu, KM Murphy Journal of Experimental Medicine 219 (7), e20211519, 2022 | 24 | 2022 |
Bcl6-independent in vivo development of functional type 1 classical dendritic cells supporting tumor rejection P Bagadia, KW O'Connor, R Wu, ST Ferris, JP Ward, RD Schreiber, ... The Journal of Immunology 207 (1), 125-132, 2021 | 7 | 2021 |
IL-6 selectively suppresses cDC1 specification via C/EBPβ S Kim, J Chen, S Jo, F Ou, ST Ferris, TT Liu, RA Ohara, DA Anderson III, ... Journal of Experimental Medicine 220 (10), e20221757, 2023 | 4 | 2023 |
cDC1 prime and receive help from CD4 T cells to promote anti-tumor responses ST Ferris, R Wu, V Durai, TL Murphy, KM Murphy The Journal of Immunology 204 (1_Supplement), 164.21-164.21, 2020 | 3 | 2020 |
Migratory CD11b+ conventional dendritic cells induce T follicular helper cell-dependent antibody responses. Science Immunology. 2017; 2 (18): eaam9169 JK Krishnaswamy, U Gowthaman, B Zhang, J Mattsson, L Szeponik, D Liu, ... | 2 | |
Enhanced in vitro type 1 conventional dendritic cell generation via the recruitment of hematopoietic stem cells and early progenitors by Kit ligand F Ou, ST Ferris, S Kim, R Wu, DA Anderson III, TT Liu, S Jo, MY Chen, ... European Journal of Immunology 53 (9), 2250201, 2023 | 1 | 2023 |
WDFY4 deficiency in NOD mice ameliorates autoimmune diabetes and insulitis ST Ferris, T Liu, J Chen, RA Ohara, F Ou, R Wu, S Kim, TL Murphy, ... Proceedings of the National Academy of Sciences 120 (13), e2219956120, 2023 | 1 | 2023 |
BCL6-dependent TCF-1+ progenitor cells maintain effector and helper CD4 T cell responses to persistent antigen Y Xia, K Sandor, JA Pai, B Daniel, S Raju, R Wu, S Hsiung, Y Qi, ... The Journal of Immunology 208 (1_Supplement), 169.08-169.08, 2022 | 1 | 2022 |
WDFY4 deficiency in NOD mice abrogates autoimmune diabetes and insulitis ST Ferris, J Chen, RA Ohara, F Ou, R Wu, S Kim, T Liu, TL Murphy, ... bioRxiv, 2022.09. 02.506326, 2022 | | 2022 |
Ablation of cDC2 lineage specification by mutations within the− 165 kb Zeb2 enhancer T Liu, S Kim, P Desai, DH Kim, X Huang, ST Ferris, R Wu, F Ou, T Egawa, ... The Journal of Immunology 208 (1_Supplement), 47.09-47.09, 2022 | | 2022 |